Company
Inspire Medical Systems, Inc.
Headquarters: Golden Valley, MN, United States
Employees: 485
CEO: Mr. Timothy P. Herbert
Market Cap
$5.65 Billion
USD as of Jan. 1, 2025
Inspire Medical Systems, Inc. Categories
United States Healthcare Medical DevicesUnited States Healthcare United States Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | $755.6 M |
| EBITDA | $18.4 M |
| Gross Profit TTM | $640.5 M |
| Profit Margin | 4.37% |
| Operating Margin | 7.05% |
| Quarterly Revenue Growth | 32.50% |
Stocks & Indices
Inspire Medical Systems, Inc. has the following listings and related stock indices.
Stock: NYSE: INSP wb_incandescent
Stock: FSX: 2DR wb_incandescent